1. Alembic Pharma
stock logo

46% Hold

Alembic Pharma Share Price

APLLTD

₹1,218.55+₹17.60 (1.47%) TodayLast updated on 26 Jul, 2024 | 14:19 IST
₹1,185.45₹1,224.90
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹21,326 Crs

Open

₹1,186.10

Close

₹1,200.95

Circuit range

₹1,441.10 - ₹960.80

Day range

₹1,185.45 - ₹1,224.90

Year range

₹701.00 - ₹1,224.90

Volume

3,94,441

Avg. traded

₹1,215.35

Revenue (12m)

₹6,229 Crs

Alembic PharmaAlembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is involved in manufacturing and marketing India Formulations, International Generics, and Active Pharmaceutical Ingredients (API). It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopaedic and Gynaecology. Products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its India Formulations. Its subsidiaries include Alembic Pharmaceuticals Inc., Alembic Global Holding SA and others.

Alembic Pharma Key indicators

arrow

52 week high

₹1,224.90

52 week low

₹701.00

P/E ratio

34.62

P/B ratio

4.9

ROE

14.3%

ROCE

14.62%

Dividend yield

0.92%

Debt/Equity ratio

0.09

EPS

33.91

Learn more

Investment checklist: (3/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Hold

arrow

Buy

27%

Hold

46%

Sell

27%

This analysis is based on the reviews of 15 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

17.53%

Net profit margin

11.35%

ROE

14.3%

ROA

10.74%

ROCE

14.62%

Learn more

Alembic Pharma Shareholder returns

arrow

1 day

+8.34%

1 week

+8.49%

1 month

+30.23%

3 months

+22.69%

1 year

+70.97%

3 years

+24.25%

5 years

+122.76%

Alembic Pharma Share Price history

arrow
DayOpenCloseDay’s change
Thu, Jul 25 2024
₹1,170.00
₹1,200.95
+2.17%
Wed, Jul 24 2024
₹1,072.90
₹1,175.40
+8.34%
Tue, Jul 23 2024
₹1,119.15
₹1,084.95
-3.05%
Mon, Jul 22 2024
₹1,088.00
₹1,119.10
+3.58%
Fri, Jul 19 2024
₹1,080.20
₹1,080.40
+0.32%
Thu, Jul 18 2024
₹1,069.00
₹1,076.95
-0.60%
Tue, Jul 16 2024
₹991.00
₹1,083.45
+10.35%
Mon, Jul 15 2024
₹993.45
₹981.85
-0.48%

Shareholding info

arrow

Promoters (69.61%)

Mutual Funds (8.05%)

Retail and other (10.6%)

Foreign institutions-FII (4.32%)

Other domestic institutions (7.42%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹11/share

    Ex date 15 Jul 2024

    expand tab
  • Dividend • ₹8/share

    Ex date 28 Jul 2023

    expand tab
  • Dividend • ₹10/share

    Ex date 17 Aug 2022

    expand tab
  • Dividend • ₹10/share

    Ex date

    expand tab

Learn more

Frequently asked questions